Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
May 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
Femasys received CE Mark approval for its FemHSG Catheter, expanding the company's fertility diagnostics portfolio into the European market.
Jan 30, 2025
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
GlobeNewswire
Read ↗
Jan 16, 2025
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
GlobeNewswire
Read ↗
Dec 3, 2024
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed
GlobeNewswire
Read ↗
Nov 26, 2024
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment
GlobeNewswire
Read ↗
Nov 20, 2024
Innovation in Women’s Reproductive Health is More Important than Ever
Medical Design & Development
Read ↗
Nov 5, 2024
Femasys Partners with Boston IVF to Expand Access to Novel Fertility Treatment
Femtech Insider
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.